D. E. Shaw & Co., Inc. Axsome Therapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $2.19 Million - $3.08 Million	31,500 New	31,500 $2.51 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $1.37 Million - $1.72 Million	-20,000 Reduced 49.02%	20,800 $1.48 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $997,400 - $1.97 Million	20,000 Added 96.15%	40,800 $3.36 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $856,960 - $2.11 Million	20,800 New	20,800 $1.22 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.